forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Outlook for obesity in 2025: more than a transition year The Multi-Sector Impacts of GLP-1RA

WWLP reported that supporters of the coverage change "believe that removing these high-cost drugs from the coverage list will allow the agency to reduce expenses significantly as it struggles to pay claims." Roughly 25.3 percent of Massachusetts children ages six to 17 are overweight or obese

Short-term exposure to sulfur dioxide (SO 2 ), PM2.5, and PM10 showed a significant correlation with hypertension

Most trial protocols used three doses per day with meals

The answer is: they can assist, but they are only one piece of the puzzle

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs

The study enrolled 40 participants and is now complete, though the data have not yet been reported